NICHOLAS PARKINSON: Open Payments
NPI 1093195638 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 55 payments from 21 companies in 2025. Trend: 2023 $832 · 2024 $1,193 · 2025 $1,079
Food & beverage: $1,079
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $139 |
| Novo Nordisk Inc | 6 | $117 |
| ABBVIE INC. | 5 | $103 |
| GlaxoSmithKline, LLC. | 6 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| Axsome Therapeutics, Inc. | 2 | $63 |
| Dexcom, Inc. | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
Products named: Kerendia, UBRELVY, Ozempic, TRELEGY ELLIPTA, Auvelity, Dexcom G6 Transmitter, REXULTI, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
